vimarsana.com

Latest Breaking News On - Vered bisker leib - Page 3 : vimarsana.com

Compass Therapeutics Announces Pricing of Approximately $125 Million Public Offering of Common Stock and Uplisting to Nasdaq Capital Market

Compass Therapeutics Announces Participation in March 2021 Investor Conferences

Search jobs Compass Therapeutics Announces Participation in March 2021 Investor Conferences BOSTON (BUSINESS WIRE) $CMPX#CompassTherapeutics Compass Therapeutics, Inc. (OTCQB: CMPX), a clinical-stage biotechnology company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies, today announced that Thomas Schuetz, MD, PhD, Co-Founder and Chief Executive Officer of Compass Therapeutics, will participate in the following virtual investor conferences: H.C. Wainwright Global Life Sciences Conference, March 9-10, 2021: Compass presentation will be broadcasted at 7:00 a.m. EST on March 9, 2021 and available on demand during the conference. 33rd Annual Roth Conference, March 15-17, 2021: as part of a live panel on bispecific antibodies that will take place at 3:00 p.m. EDT on Tuesday, March 16, 2021.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.